Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q3 FY20 results · Oct–Dec 2019
Procter & Gamble Health reported revenue from operations of ₹236.77 crore (up 15.8% from Q3 FY19) and net profit of ₹38.21 crore (down 94.7% from Q3 FY19) for Q3 FY20 (Oct–Dec 2019), on a standalone basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 236.77 | 204.39 | +15.8% | 225.17 | +5.2% |
| Other income | 6.06 | 7.17 | −15.6% | 6.72 | −9.9% |
| Total income | 242.82 | 211.57 | +14.8% | 231.89 | +4.7% |
| Profit before tax | 50.80 | 17.89 | +183.9% | 52.58 | −3.4% |
| Net profit for the period | 38.21 | 715.34 | −94.7% | 35.76 | +6.9% |
| EPS, basic (₹) | 23.02 | 430.94 | −94.7% | 21.54 | +6.9% |
| Net margin (%) | 16.1 | 350.0 | 15.9 |
Standalone
- Filed with BSE
- 07 Feb 2020, 15:58 IST
- Board meeting
- 07 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE